
Sign up to save your podcasts
Or


Despite its success in rushing COVID-19 vaccines to market, the biopharmaceutical supply chain is far from perfect.
By Bob Bowman4.2
1717 ratings
Despite its success in rushing COVID-19 vaccines to market, the biopharmaceutical supply chain is far from perfect.

32,220 Listeners

30,643 Listeners

11,164 Listeners

26,049 Listeners

3,239 Listeners

4,422 Listeners

1,470 Listeners

2,242 Listeners

1,032 Listeners

6,455 Listeners

345 Listeners

9,150 Listeners

6,106 Listeners

10,243 Listeners

215 Listeners